Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta‐Analysis of Direct Comparative Studies

Tirzepatide Versus Semaglutide on Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta‐Analysis of Direct Comparative Studies

ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have emerged as an efficacious treatment for type 2 diabetes mellitus (T2DM) and have demonstrated substantial weight loss effects. This systematic review compares two prevalent GLP‐1RAs, tirzepatide and semaglutide, with the...

Full description

Saved in:
Bibliographic Details
Main Authors: Jimmy Wen, Burhaan Syed, Denise Nadora, Christiane How‐Volkman, Ethan Bernstein, Alina Truong, Muzammil Akhtar, Adam Razick, Jose Puglisi, Eldo Frezza
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
diabetes
meta‐analysis
semaglutide
tirzepatide
weight loss
Online Access:https://doi.org/10.1002/edm2.70045
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/edm2.70045

Similar Items